Background Urogenital gonorrhoea is a growing public health concern due to the rise of Neisseria gonorrhoeae strains resistant to current therapies, including cephalosporins and azithromycin. Gepotidacin is a first-in-class, oral triazaacenaphthylene antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV. This Phase 2 study evaluated it
1573 Reached7 Comments
Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments
Woman presented with Fever of Unknown Origin
7744 Reached93 Comments19 Likes
How Physicians Should Manage Stress?
35340 Reached151 Comments202 Likes
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Pregnant Woman with HIV-1 Infection
747 Reached1 Likes